Time | Control | BM-MSCs |
---|
Low-dose | High-dose |
---|
6 months | −3 (−6, 0) | 0 (−1, 0) | 0 (−1, 1) |
12 months | −4 (−18, 0) | 0 (0, 3) | 0 (−1, 2) |
- For each group of treatment, variation for knee joint space width, which was measured in mm, was calculated by subtracting, for each patient of the group, the value at 6 or 12Â months from the baseline value. Data are presented as the median (IQR) of each group